Amgen Announces Webcast Of 2015 First Quarter Financial Results Apr 16, 2015 04:05PM
FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure Apr 15, 2015 05:04PM
European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer Apr 6, 2015 05:00AM
Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference Mar 30, 2015 04:07PM
FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma Mar 30, 2015 09:00AM

Mar 26, 2015 04:01PM Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer
Mar 23, 2015 09:00AM Amgen To Webcast Investor Call At the 73rd Annual Meeting of the American Academy of Dermatology
Mar 20, 2015 09:00AM Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In Japan
Mar 17, 2015 04:01PM Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology
Mar 15, 2015 11:00AM Amgen Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha™ (evolocumab) In The New England Journal of Medicine
Mar 14, 2015 12:30PM New Detailed Data From Phase 3 Study Show Amgen's Repatha™ (Evolocumab) In Combination With Statins Reduced LDL-C By 67-76 Percent Compared To Placebo In Japanese Patients With High Cardiovascular R
Mar 4, 2015 04:30PM Amgen Announces 2015 Second Quarter Dividend
Mar 2, 2015 04:30PM Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data
Mar 2, 2015 04:01PM Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit
Mar 1, 2015 07:00PM Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma
Feb 27, 2015 09:00AM Amgen Receives Positive CHMP Opinion For Use Of Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Advanced Colorectal Cancer
Feb 26, 2015 04:05PM Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma
Feb 25, 2015 04:44PM Amgen Announces Positive Results From Head-To-Head Study Comparing The Efficacy And Safety Of AMG 416 With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
Feb 25, 2015 04:04PM Amgen To Present At The Cowen And Company 35th Annual Health Care Conference
Feb 11, 2015 04:22PM Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma
Feb 3, 2015 04:01PM Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Rheumatoid
Jan 29, 2015 04:40PM Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia
Jan 27, 2015 04:02PM Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma
Jan 27, 2015 04:01PM Amgen's 2014 Revenues Increased 7 Percent To $20.1 Billion And Adjusted Earnings Per Share (EPS) Increased 14 Percent To $8.70
Jan 22, 2015 04:01PM Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results
Oct 28, 2014 09:33AM Pre-Open Stock Movers 10/28: (RCPT) (TRNX) (VDSI) (MSG) Higher; (TWTR) (AMKR) (CVLT) Lower (more...)
Oct 27, 2014 06:22PM After-Hours Stock Movers 10/27: (TRNX) (RCPT) (SANM) Higher; (AKMR) (TWTR) (KSS) Lower (more...)
Oct 14, 2014 10:03AM UPDATE: Gilead Sciences (GILD) Hits Session Lows
Jul 30, 2014 10:29AM Top 10 Trending Stocks for 07/30: Twitter (TWTR), Amgen (AMGN), Regeneron (REGN), and More...
Jul 30, 2014 09:32AM Pre-Open Stock Movers 7/30: (GFIG) (TWTR) (NQ) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 06:10PM After-Hours Stock Movers 7/29: (TWTR) (ZLTQ) (X) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
Jul 29, 2014 05:37PM Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple
Jul 28, 2014 05:11PM Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report